217 related articles for article (PubMed ID: 16120141)
1. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
Harries MJ; Chalmers RJ; Griffiths CE
Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
[TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
[TBL] [Abstract][Full Text] [Related]
7. Proteinuria with fumaric acid ester treatment for psoriasis.
Ogilvie S; Lewis Jones S; Dawe R; Foerster J
Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
[TBL] [Abstract][Full Text] [Related]
8. Fumaric acid esters for psoriasis: a systematic review.
Smith D
Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
[TBL] [Abstract][Full Text] [Related]
10. Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.
Dickel H; Bruckner T; Höxtermann S; Dickel B; Trinder E; Altmeyer P
J Eur Acad Dermatol Venereol; 2019 May; 33(5):893-905. PubMed ID: 30680823
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST).
Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I
J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304
[TBL] [Abstract][Full Text] [Related]
12. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.
Balak DMW; Hajdarbegovic E; Bramer WM; Neumann HAM; Thio HB
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1475-1482. PubMed ID: 28322482
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS).
Thaçi D; Weisenseel P; Philipp S; Rosenbach T; Rotterdam S; Augustin M; Neureither M; Reich K
J Dtsch Dermatol Ges; 2013 May; 11(5):429-35. PubMed ID: 23433431
[TBL] [Abstract][Full Text] [Related]
15. Fumaric acid esters in the management of psoriasis.
Balak DM
Psoriasis (Auckl); 2015; 5():9-23. PubMed ID: 29387578
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
17. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
Dickel H; Bruckner T; Altmeyer P
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
[TBL] [Abstract][Full Text] [Related]
18. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
Schmieder A; Poppe M; Hametner C; Meyer-Schraml H; Schaarschmidt ML; Findeisen P; Benoit S; Bauer B; Schmid S; Goebeler M; Goerdt S; Ludwig-Peitsch WK
Arch Dermatol Res; 2015 Jul; 307(5):413-24. PubMed ID: 25648959
[TBL] [Abstract][Full Text] [Related]
19. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study.
Kreuter A; Knierim C; Stücker M; Pawlak F; Rotterdam S; Altmeyer P; Gambichler T
Br J Dermatol; 2005 Oct; 153(4):802-7. PubMed ID: 16181464
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid esters in the management of severe psoriasis.
Brewer L; Rogers S
Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
